CRLVSSXTC• 28 Days (Normalized)
CRL vs SXTC (Charles River Laboratories International Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CRL Performance $304.96
+8.62%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
SXTC Performance $1.25
-44.2%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
+52.82 pts
CRL outperforming by 52.82 percentage points
CRLSXTC
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CRL SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | CRL Price | CRL Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $304.96 | +8.62% | $1.25 | -44.20% | +52.82% |
| Oct 05, 2026 | $310.77 | +10.69% | $2.08 | -7.14% | +17.83% |
| Oct 02, 2026 | $290.19 | +3.36% | $2.41 | +7.59% | -4.23% |
| Oct 01, 2026 | $286.83 | +2.16% | $2.96 | +32.14% | -29.98% |
| Sep 30, 2026 | $295.01 | +5.08% | $3.01 | +34.37% | -29.29% |
| Sep 29, 2026 | $295.96 | +5.41% | $2.81 | +25.45% | -20.04% |
| Sep 28, 2026 | $294.59 | +4.93% | $2.52 | +12.50% | -7.57% |
| Sep 25, 2026 | $292.84 | +4.30% | $- | - | |
| Sep 23, 2026 | $277.33 | -1.22% | $2.51 | +12.05% | -13.27% |
| Sep 22, 2026 | $285.11 | +1.55% | $- | - | |
| Sep 21, 2026 | $279.01 | -0.62% | $2.38 | +6.25% | -6.87% |
| Sep 18, 2026 | $278.06 | -0.96% | $2.40 | +7.14% | -8.10% |
| Sep 17, 2026 | $281.67 | +0.32% | $2.44 | +8.71% | -8.39% |
| Sep 16, 2026 | $273.41 | -2.62% | $2.19 | -2.23% | -0.39% |
| Sep 15, 2026 | $272.88 | -2.81% | $2.36 | +5.36% | -8.17% |
Page 1 of 2